EBITDA for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current EBITDA (TTM) is $10.80B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$10.80B
YoY change
+6.6%
5Y CAGR
+5.1%
Peak year (2021)
$12.16B
Cumulative EBITDA
$216.90B
EBITDA history chart for Abbott Laboratories (ABT) from 1985 to 2025
EBITDA history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $11.55B | +6.6% | ||
| 2024 | $10.83B | +2.2% | ||
| 2023 | $10.61B | -10.8% | ||
| 2022 | $11.89B | -2.2% | ||
| 2021 | $12.16B | +35.1% | ||
| 2020 | $9.00B | +13.8% | ||
| 2019 | $7.91B | +15.0% | ||
| 2018 | $6.88B | +12.2% | ||
| 2017 | $6.13B | +99.7% | ||
| 2016 | $3.07B | -36.5% | ||
| 2015 | $4.83B | +16.3% | ||
| 2014 | $4.16B | +15.3% | ||
| 2013 | $3.60B | +3.1% | ||
| 2012 | $3.50B | -62.2% | ||
| 2011 | $9.26B | +1.3% | ||
| 2010 | $9.14B | -3.7% | ||
| 2009 | $9.49B | +15.4% | ||
| 2008 | $8.22B | +18.9% | ||
| 2007 | $6.92B | +62.7% | ||
| 2006 | $4.25B | -31.7% | ||
| 2005 | $6.22B | +10.8% | ||
| 2004 | $5.61B | +33.6% | ||
| 2003 | $4.20B | -2.4% | ||
| 2002 | $4.30B | -2.0% | ||
| 2001 | $4.39B | +3.9% | ||
| 2000 | $4.23B | +6.3% | ||
| 1999 | $3.98B | +1.9% | ||
| 1998 | $3.90B | +9.6% | ||
| 1997 | $3.56B | +7.9% | ||
| 1996 | $3.30B | +12.0% | ||
| 1995 | $2.95B | +11.1% | ||
| 1994 | $2.65B | +10.2% | ||
| 1993 | $2.41B | +23.2% | ||
| 1992 | $1.95B | +0.9% | ||
| 1991 | $1.94B | +9.9% | ||
| 1990 | $1.76B | +15.3% | ||
| 1989 | $1.53B | +11.3% | ||
| 1988 | $1.37B | +9.9% | ||
| 1987 | $1.25B | +15.9% | ||
| 1986 | $1.08B | +20.7% | ||
| 1985 | $892.90M | — |
EBITDA values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) EBITDA totalled $11.55B – grew 6.6% year-over-year.
Over 2020–2025 (5 years), Abbott Laboratories EBITDA expanded at a +5.1% compound annual rate, sustaining 2 straight years of year-over-year growth.
Abbott Laboratories EBITDA peaked at $12.16B in 2021; the latest annual figure is $11.55B in 2025 (5.0% below peak).
2021 marks the peak EBITDA at $12.16B, with the historical low of $892.90M recorded in 1985.
Within Healthcare, Abbott Laboratories (ABT) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Abbott Laboratories EBITDA by Year
Abbott Laboratories EBITDA 2025: $11.55B
Abbott Laboratories EBITDA in 2025 was $11.55B, grew 6.6% from 2024.
Abbott Laboratories EBITDA 2024: $10.83B
Abbott Laboratories EBITDA in 2024 was $10.83B, edged up 2.2% from 2023.
Abbott Laboratories EBITDA 2023: $10.61B
Abbott Laboratories EBITDA in 2023 was $10.61B, declined 10.8% below 2022.
Abbott Laboratories EBITDA 2022: $11.89B
Abbott Laboratories EBITDA in 2022 was $11.89B, edged down 2.2% below 2021.
Abbott Laboratories EBITDA 2021: $12.16B
Abbott Laboratories EBITDA in 2021 was $12.16B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — EBITDA
Companies in the same sector as Abbott Laboratories, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's EBITDA?
- Latest reported EBITDA for Abbott Laboratories (ABT) is $10.80B (period ending March 31, 2026).
How has Abbott Laboratories EBITDA changed year-over-year?
- Abbott Laboratories (ABT) EBITDA changed +6.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories EBITDA?
- Abbott Laboratories (ABT) EBITDA compound annual growth rate is +5.1% over the most recent 5 years available.
When did Abbott Laboratories EBITDA hit its highest annual value?
- Abbott Laboratories EBITDA reached its highest annual value of $12.16B in 2021.
What was Abbott Laboratories EBITDA in 2024?
- Abbott Laboratories (ABT) EBITDA in 2024 was $10.83B.
What was Abbott Laboratories EBITDA in 2025?
- Abbott Laboratories (ABT) EBITDA in 2025 was $11.55B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.